RVVTF

Revive Therapeutics Ltd. RVVTF

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode RVVTF STHZF LMLLF CNGGF TNRG CTABF RAFA TGIFF CPIVF CANN
6M -55.76 % -93.33 % 83.09 % -38.00 % -50.00 % 0.00 % -37.50 % 146.51 % 131.48 % 98.10 %
YTD 40.38 % -93.33 % 19.71 % -48.33 % -99.00 % 0.00 % -65.00 % 112.00 % 19.05 % 103.21 %
1Y 19.67 % -93.33 % 46.47 % -48.33 % -99.00 % 0.00 % -49.64 % 107.84 % 150.00 % 62.33 %
3Y -92.70 % -98.52 % -83.45 % -95.23 % -99.00 % -98.89 % -92.39 % -4.50 % 127.27 % -66.56 %
5Y -98.64 % -99.94 % -97.45 % -98.74 % -99.82 % -99.99 % -97.50 % -79.71 % -89.41 % -92.43 %
10Y -98.33 % -99.98 % -98.86 % -98.74 % -100.00 % -100.00 % 600.00 % -93.38 % -82.14 % -93.03 %
From the beginning -98.61 % -99.98 % -98.86 % -98.74 % -100.00 % -100.00 % -97.41 % -93.38 % -82.14 % -62.00 %

Dividend